Clinical Trials Browser

Phase 3 × Breast Neoplasms × Control Groups × Clear all

NCT05063136 2024-11-04

Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer

Phase 3 Recruiting

Breast Neoplasms

NCT04385433 2023-08-24

PRAVAPREV-01

Phase 3 Terminated

Breast Neoplasms

NCT03971019 2019-08-14

SBSBC

Phase 3 Unknown

Breast Neoplasms

NCT00582244 2007-12-28

EVA project

Phase 3 Unknown

Breast Neoplasms